Relative etiological role of prior hepatitis B virus infection and nonalcoholic fatty liver disease in the development of non-B non-C hepatocellular carcinoma in a hepatitis B-endemic area

Digestion

Volumn 84, Issue SUPPL. 1, 2011, Pages 17-22

  Cho, Eun Ju ^a   Kwack, Min Sun ^a   Jang, Eun Sun ^a   You, Su Jong ^a   Lee, Jeong Hoon ^a   Kim, Yoon Jun ^a   Yoon, Jung Hwan ^a   Lee, Hyo Suk ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Etiology; Hepatitis B core antibody; Hepatocellular carcinoma; Nonalcoholic fatty liver disease

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; VIRUS ANTIBODY;

ADULT; AGE; AGED; ARTICLE; CANCER PATIENT; CANCER RISK; DIABETES MELLITUS; DISEASE ASSOCIATION; ENDEMIC DISEASE; FEMALE; HEPATITIS B; HUMAN; KOREA; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; PRIORITY JOURNAL; VIRUS CARCINOGENESIS;

AGED; CARCINOMA, HEPATOCELLULAR; ENDEMIC DISEASES; FATTY LIVER; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; REPUBLIC OF KOREA; RISK FACTORS;

EID: 83755172768     PISSN: 00122823     EISSN: 14219867     Source Type: Journal    
DOI: 10.1159/000333210     Document Type: Article

References (30)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin 2011.
2. Yang JD, Roberts LR: Hepatocellular carcinoma: a global view. Nat Rev Gastroenterol Hepatol 2010; 7: 448-458.
3. Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB: Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut 2005; 54: 533-539. (Pubitemid 40403031)
4. Abe H, Yoshizawa K, Kitahara T, Aizawa R, Matsuoka M, Aizawa Y: Etiology of non-B non-C hepatocellular carcinoma in the eastern district of Tokyo. J Gastroenterol 2008; 43: 967-974.
5. Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, Carucci P, Musso A, De Paolis P, Capussotti L, Salizzoni M, Rizzetto M: Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002; 123: 134-140. (Pubitemid 34747534)
6. Harrison SA, Torgerson S, Hayashi PH: The natural history of nonalcoholic fatty liver disease: a clinical histopathological study. Am J Gastroenterol 2003; 98: 2042-2047. (Pubitemid 37185803)
7. Marrero JA, Fontana RJ, Su GL, Conjeevaram HS, Emick DM, Lok AS: NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology 2002; 36: 1349-1354. (Pubitemid 35403524)
8. Hashimoto E, Yatsuji S, Tobari M, Taniai M, Torii N, Tokushige K, Shiratori K: Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. J Gastroenterol 2009; 44(suppl 19):89-95.
9. Matsuzaki Y, Sato M, Saito Y, Karube M, Doy M, Shoda J, Abei M, Tanaka N, Hadama T, Kinoshita M: The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study. J Exp Clin Cancer Res 1999; 18: 379-389.
10. Tamori A, Nishiguchi S, Kubo S, Narimatsu T, Habu D, Takeda T, Hirohashi K, Shiomi S: HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan. J Med Virol 2003; 71: 92-498.
11. Berasain C, Betes M, Panizo A, Ruiz J, Herrero JI, Civeira MP, Prieto J: Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology. Gut 2000; 47: 429-435.
12. Chan HL, Tsang SW, Leung NW, Tse CH, Hui Y, Tam JS, Chan FK, Sung JJ: Occult HBV infection in cryptogenic liver cirrhosis in an area with high prevalence of HBV infection. Am J Gastroenterol 2002; 97: 1211-1215. (Pubitemid 34478124)
13. Fukuda R, Ishimura N, Kushiyama Y, Moriyama N, Ishihara S, Chowdhury A, Tokuda A, Sakai S, Akagi S, Watanabe M, Fukumoto S: Hepatitis B virus with × gene mutation is associated with the majority of serologically 'silent' non-B, non-C chronic hepatitis. Microbiol Immunol 1996; 40: 481-488. (Pubitemid 126481263)
14. Korean Liver Cancer Study Group and National Cancer Center: Practice guidelines for management of hepatocellular carcinoma 2009. Korean J Hepatol 2009; 15: 391-423.
15. Hamer OW, Aguirre DA, Casola G, Lavine JE, Woenckhaus M, Sirlin CB: Fatty liver: imaging patterns and pitfalls. Radiographics 2006; 26: 1637-1653.
16. Bell BP, Manos MM, Zaman A, Terrault N, Thomas A, Navarro VJ, Dhotre KB, Murphy RC, Van Ness GR, Stabach N, Robert ME, Bower WA, Bialek SR, Sofair AN: The epidemiology of newly diagnosed chronic liver disease in gastroenterology practices in the United States: results from population-based surveillance. Am J Gastroenterol 2008; 103: 2727-2736, quiz 2737.
17. Michitaka K, Nishiguchi S, Aoyagi Y, Hiasa Y, Tokumoto Y, Onji M: Etiology of liver irrhosis in Japan: a nationwide survey. J Gastroenterol 2010; 45: 86-94.
18. Caldwell SH, Crespo DM, Kang HS, Al- Osaimi AM: Obesity and hepatocellular carcinoma. Gastroenterology 2004; 127:S97-S103. (Pubitemid 39423375)
19. Chen CL, Yang HI, Yang WS, Liu CJ, Chen PJ, You SL, Wang LY, Sun CA, Lu SN, Chen DS, Chen CJ: Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology 2008; 135: 111-121.
20. Sanchez-Quijano A, Jauregui JI, Leal M, Pineda JA, Castilla A, Abad MA, Civeira MP, Garcia de Pesquera F, Prieto J, Lissen E: Hepatitis B virus occult infection in subjects with persistent isolated anti-HBC reactivity. J Hepatol 1993; 17: 288-293. (Pubitemid 23134923)
21. Chemin I, Zoulim F, Merle P, Arkhis A, Chevallier M, Kay A, Cova L, Chevallier P, Mandrand B, Trepo C: High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology. J Hepatol 2001; 34: 447-454. (Pubitemid 32240826)
22. Shim J, Kim BH, Kim NH, Dong SH, Kim HJ, Chang YW, Lee JI, Chang R: Clinical features of HBsAg-negative but anti-HBC-positive hepatocellular carcinoma in a hepatitis B virus endemic area. J Gastroenterol Hepatol 2005; 20: 746-751. (Pubitemid 40733370)
23. Fang Y, Shang QL, Liu JY, Li D, Xu WZ, Teng X, Zhao HW, Fu LJ, Zhang FM, Gu HX: revalence of occult hepatitis B virus infection among hepatopathy patients and healthy people in China. J Infect 2009; 58: 383-388.
24. Chitturi S, Farrell GC, Hashimoto E, Saibara T, Lau GK, Sollano JD: Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines. J Gastroenterol Hepatol 2007; 22: 778-787. (Pubitemid 46915352)
25. Oh KC, Park SH, Park JC, Jin DK, Park CS, Kim KO, Jang HJ, Lee JY, Park CH, Han TH, Yoo KS, Kim JH, Kim DJ, Lee MS, Park CK: Is the prevalence of cryptogenic hepatocellular carcinoma increasing in Korea? (in Korean). Korean J Gastroenterol 2005; 45: 45-51.
26. Park NH, Chung YH, Lee HS: Impacts of vaccination on hepatitis B viral infections in Korea over a 25-year period. Intervirology 2010; 53: 20-28.
27. Bugianesi E: Non-alcoholic steatohepatitis and cancer. Clin Liver Dis 2007; 11: 191-207, x-xi. (Pubitemid 46829971)
28. Starley BQ, Calcagno CJ, Harrison SA: Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology 2010; 51: 1820-1832.
29. Kusakabe A, Tanaka Y, Orito E, Sugauchi F, Kurbanov F, Sakamoto T, Shinkai N, Hirashima N, Hasegawa I, Ohno T, Ueda R, Mizokami M: A weak association between occult HBV infection and non-B non-C hepatocellular carcinoma in Japan. J Gastroenterol 2007; 42: 298-305. (Pubitemid 46681705)
30. Raimondo G, Allain JP, Brunetto MR, Buendia MA, Chen DS, Colombo M, Craxi A, Donato F, Ferrari C, Gaeta GB, Gerlich WH, Levrero M, Locarnini S, Michalak T, Mondelli MU, Pawlotsky JM, Pollicino T, Prati D, Puoti M, Samuel D, Shouval D, Smedile A, Squadrito G, Trepo C, Villa E, Will H, Zanetti AR, Zoulim F: Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol 2008; 49: 652-657.